Jamjiro, Shaimen E.
HRN: 29-04-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
AMPICILLIN 250MG (VIAL)
06/04/2026
06/11/2026
IV
130mg
Q12
Omphalitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes